Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research communications

Showing results (11-20 of 963) with videos related to

Pageof 97
Sort By:
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
Cancer Research Communications|July 21, 2025
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular VesiclesJared Sipes, Didi Zha, Sagar Rayamajhi, et al.
Cancer Research Communications|July 17, 2025
Assessing MC1R Variants in Lentigo Maligna Melanoma within the Utah PopulationAmanda Jiang, Annabelle Huntsman, Carly Becker, et al.
Cancer Research Communications|July 22, 2025
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer ImmunotherapyZhijun Zhou, Yang Cai, Hao Yuan, et al.
Cancer Research Communications|June 3, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic TargetTakuma Yoshimura, Takashi Kamatani, Aki Ookubo, et al.
Cancer Research Communications|June 18, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without LymphocytopeniaMasayuki Nagahashi, Miki Komatsu, Sayaka Urano, et al.
Cancer Research Communications|June 6, 2025
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma CellsStacia L Koppenhafer, Elizabeth L Geary, Mary V Thomas, et al.
Cancer Research Communications|June 6, 2025
Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American WomenDaniela Alves da Quinta, Darío Rocha, Cristian Yáñez, et al.
Cancer Research Communications|June 4, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated ToxicitiesSanja Karovic, Erik Dvergsten, Chiara Pierattini, et al.
Cancer Research Communications|October 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic SarcomaMiguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira, et al.
Pageof 97

Showing results (11-20 of 963) with videos related to

Sort By:
Pageof 97
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
Cancer Research Communications|July 21, 2025
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular VesiclesJared Sipes, Didi Zha, Sagar Rayamajhi, et al.
Cancer Research Communications|July 17, 2025
Assessing MC1R Variants in Lentigo Maligna Melanoma within the Utah PopulationAmanda Jiang, Annabelle Huntsman, Carly Becker, et al.
Cancer Research Communications|July 22, 2025
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer ImmunotherapyZhijun Zhou, Yang Cai, Hao Yuan, et al.
Cancer Research Communications|June 3, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic TargetTakuma Yoshimura, Takashi Kamatani, Aki Ookubo, et al.
Cancer Research Communications|June 18, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without LymphocytopeniaMasayuki Nagahashi, Miki Komatsu, Sayaka Urano, et al.
Cancer Research Communications|June 6, 2025
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma CellsStacia L Koppenhafer, Elizabeth L Geary, Mary V Thomas, et al.
Cancer Research Communications|June 6, 2025
Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American WomenDaniela Alves da Quinta, Darío Rocha, Cristian Yáñez, et al.
Cancer Research Communications|June 4, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated ToxicitiesSanja Karovic, Erik Dvergsten, Chiara Pierattini, et al.
Cancer Research Communications|October 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic SarcomaMiguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira, et al.
Pageof 97